Avanafil: A Comprehensive Overview
Pharmacokinetics of Avanafil Avanafil, known for its effectiveness, operates as a selective PDE5 inhibitor. It specifically targets enzymes responsible for erectile dysfunction. When consumed, avanafil 100 mg swiftly enters the bloodstream. Its absorption peaks approximately 30-45 minutes post-ingestion. This rapid onset is a key attribute, differentiating it from other phosphodiesterase inhibitors. The liver metabolizes avanafil predominantly through cytochrome P450 enzymes, specifically CYP3A4 and, to a lesser extent, CYP2C9. The substance exhibits a half-life of around […]